NCT04672278

Lipid-Lowering Effect and Hypotensive Effect of Shanzha Fruit Drink in Patients

Completed NA Last updated 23 April 2021

What this trial tests

NA trial testing Shanzha Fruit drink or placebo drink in Hyperlipidemia in 72 participants. Completed in 30 October 2020.

Timeline

2 January 2019

Primary endpoint
30 October 2020

30 October 2020

Quick facts

Lead sponsor	Chinese University of Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	72
Start date	2 January 2019
Primary completion	30 October 2020
Estimated completion	30 October 2020
Sites	1 location across Hong Kong

Drugs / interventions tested

• Shanzha Fruit drink or placebo drink

Conditions studied

• Hyperlipidemia — all drugs for Hyperlipidemia →
• Hypertension — all drugs for Hypertension →

Sponsor

Chinese University of Hong Kong

Who can join

Adults 18 to 75, any sex, with Hyperlipidemia or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center, randomized, double-blind, placebo-controlled, cross-over study. Subjects who meet the inclusion/exclusion criteria will be randomly and alternatively assigned to receive Shanzha fruit drink or placebo drink in the first 2 months or the last two months of the 5 months study period. In between the first and second treatment period, all patients will enter a Washout Period of 4 weeks and during which time patients should not receive any of the study functional fruit drink.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Effects of Hawthorn Fruit Extract Drink in Chinese Patients With Mild Hypertension and/or Hyperlipidaemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
   Zeng W, Chu TTW, Fok BSP, Ho WKK, et al · · 2024 · cited 1× · PMID 39583031 · DOI 10.1177/15593258241303136